3 products found

Akoya Biosciences products

Advanced Biopharma Solutions (ABS)

As inventors of the PhenoImager™ technology (formerly Phenoptics™), we leverage deep expertise in multiplex imaging and cutting-edge spatial technologies to design and develop your next-generation spatial biomarker assays. Our CLIA-certified lab provides a wide range of service offerings to meet your translational and clinical research needs. Akoya’s Advanced Biopharma Solutions (ABS) is a premium service for biopharmaceutical companies who want to discover and develop actionable spatial biomarkers for their translational pathology and immunotherapy programs.

The PhenoCycler Solution

Characterizing the complexities of the tissue microenvironment is a critical step towards understanding molecular and cellular mechanisms associated with disease development, differentiation, and response. The PhenoCycler®-Fusion allows spatial phenotyping of millions of cells at unprecedented scale and speed. Mapping millions of cells and their interactions across single intact tissue sections facilitates the discovery of rare cell types, cellular neighborhoods, and spatial functional states. Push the frontiers of spatial biology with your team using the PhenoCycler solutions (formerly CODEX®).

The PhenoImager Solution

Unraveling the complex and dynamic tumor microenvironment requires the assessment of spatial relationships between tumor and immune cells. Multiplex imaging utilizing tumor and immunologic markers can reveal the spatial relationships between tumor and immune cells, leading to the discovery of spatial signatures, a new class of highly predictive biomarkers that measure the interactions and cellular densities of tumor and immune cells that compose the tumor microenvironment. Our PhenoImager® Instruments, powered by patented Multispectral Imaging (MSI) Technology, are the fastest quantitative digital pathology imaging platforms enabling rapid and accurate spatial phenotyping at scale. Pave the path for spatial signatures with your team using the PhenoImager and the newly launched PhenoCode™ Signature Panels.